Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice-Reference-Cited by-同舟云学术

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

Published:2017-09 Issue:3 Volume:72 Page:389-399
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Chapple Christopher R.,Nazir Jameel,Hakimi Zalmai,Bowditch Sally,Fatoye Francis,Guelfucci Florent,Khemiri Amine,Siddiqui Emad,Wagg Adrian

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Urology,2003

2. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

3. The management of lower urinary tract symptoms in men: NICE guideline CG97;National Institute for Health and Care Excellence,2010

4. The management of urinary incontinence in women: NICE guideline CG171;National Institute for Health and Care Excellence,2013

5. Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder;Oefelein;Drug Saf,2011

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The peptide regulator Vezusten in the management of overactive bladder syndrome: an efficacy evaluation;Urology Herald;2024-09-06

2. How can we explain the poor medication adherence in patients with overactive bladder syndrome?;Hellenic Urology;2024-07

3. Botulinumtoxin A bei idiopathischer Blasenüberaktivität (iOAB) der Frau;Die Urologie;2024-06-26

4. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices;Advances in Therapy;2024-05-15

5. Does the setting for intradetrusor onabotulinumtoxinA injection for management of overactive bladder matter?;Indian Journal of Urology;2024-04